“…Cancer germline antigens derive from proteins that are naturally expressed during foetal development and in certain types of tumours but are usually unexpressed in adult normal tissues. The most investigated cancer germline antigens are NY-ESO-1 and MAGE-A antigens, first reported in patients with synovial cell sarcoma or melanoma [ 36 , 37 , 38 , 39 , 40 , 41 ], but also described in several other types of tumours [ 38 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 ]. Differentiation antigens are specific proteins from tissue or cells, both healthy and affected, where the tumour is occurring, but that are not expressed in other tissues, as CD19 in most of B cell lymphomas [ 35 , 54 ] or gp100 and MART-1 in melanoma [ 55 , 56 ]).…”